Our cardiology team joined the global community at the American College of Cardiology (ACC) 2026 conference & exchanged knowledge; from tackling acute coronary syndrome controversies to insights on Lp(a) & post-heart attack therapies, we’re proud to contribute to the field.
Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology: @JACCJournals and @ACCinTouch
🥸 Inflammation and aging are interlinked: #inflammaging
😱 Great science statement here
👇👇👇
After 30 years of primary PCI we now have an objective definition of the most common #ECG pattern of STEMI.
Hyperacute T-waves specific for acute coronary occlusion now defined using #AI in @JACCJournals!
EECP therapy improves cerebral blood flow in symptomatic severe intracranial stenosis. Dr Vijay Sharma and Dr May Zin presented our RCT findings today at #ESOC2025. Larger validation studies needed!
Heart failure’s rising global incidence calls for new treatments. Research into epigenetic mechanisms—like DNA methylation & histone modifications—shows promise for understanding & targeting heart failure. Article avail at: https://t.co/x5rNwpscJW
💥AMIODARONE is a class III antiarrhythmic drug which is widely used in ER for treating arrhythmias.
A 🧵 on situations where blind use of amiodarone in emergency can be counterproductive ⚠️⚠️⚠️
With alternate therapeutic options
Read on...👇
#MedTwitter#MedEd#MedX
#NUHCS proudly presented a record-breaking 18 oral abstracts from SG, at @escardio Congress 2024. Focused on personalising cardiovascular care to improve patient outcomes, our team continues to advance cardiac care via research & collaboration to shape the future of CV medicine.
Looking at the amazing number of attendees from NUHCS nuh and nus at esc London ! We are the biggest group among the three healthcare clusters also with record breaking of 18 abstracts presented in the last four days here in London 🤩